---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-012201"
form_type: "8-K"
ticker: "TCRT"
cik: "0001107421"
company_name: "Alaunos Therapeutics, Inc."
filed_at: "2024-01-22T23:59:59+00:00"
generated_at: "2026-06-06T20:28:42.745027+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Alaunos Therapeutics names Dale Hogue as Interim CEO, effective Jan 20, 2024

## Summary
- Dale Curtis Hogue, Jr. appointed Interim CEO; will continue serving on the Board.
- Hogue founded family office Dune Lake Capital; spent 8 years as senior analyst at Discovery Capital Management.
- Employment terms: $250,000 base salary; option to buy 600,000 shares at $0.12.
- Option vests 50,000 shares monthly over 12 months subject to continued employment; unvested shares forfeited.

## SEC filing metadata
- accession: 0001193125-24-012201
- form_type: 8-K
- ticker: TCRT
- cik: 0001107421
- company_name: Alaunos Therapeutics, Inc.
- filed_at: 2024-01-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1107421/000119312524012201/0001193125-24-012201-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1107421/000119312524012201/d732206d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-012201
- JSON: https://secwatch.observer/filing/0001193125-24-012201.json
- Plain text: https://secwatch.observer/filing/0001193125-24-012201.txt

## Key facts
- Executive change
  Dale Curtis Hogue, Jr. was appointed as Interim Chief Executive Officer at Alaunos Therapeutics, Inc..
  - Action: appointed
  - Role: Interim Chief Executive Officer
  source text: On January 20, 2024, the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) appointed Dale Curtis Hogue, Jr. as Interim Chief Executive Officer of the Company, effective January 20, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1107421/000119312524012201/0001193125-24-012201-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.